Guggenheim Capital’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2
| Closed | -$9K | – | 2653 |
|
|
2018
Q1 | $9K | Hold |
2
| – | – | ﹤0.01% | 2764 |
|
|
2017
Q4 | $9K | Hold |
2
| – | – | ﹤0.01% | 2692 |
|
|
2017
Q3 | $15K | Buy |
2
+1
| +100% | +$7.5K | ﹤0.01% | 2761 |
|
|
2017
Q2 | $12K | Hold |
1
| – | – | ﹤0.01% | 2802 |
|
|
2017
Q1 | $17K | Hold |
1
| – | – | ﹤0.01% | 2795 |
|
|
2016
Q4 | $18K | Hold |
1
| – | – | ﹤0.01% | 2857 |
|
|
2016
Q3 | $22K | Hold |
1
| – | – | ﹤0.01% | 2820 |
|
|
2016
Q2 | $15K | Hold |
1
| – | – | ﹤0.01% | 2826 |
|
|
2016
Q1 | $17K | Buy |
+1
| New | +$17K | ﹤0.01% | 2835 |
|
|
2014
Q3 | – | Sell |
-1
| Closed | -$35K | – | 3082 |
|
|
2014
Q2 | $35K | Sell |
1
-1
| -50% | -$35K | ﹤0.01% | 3070 |
|
|
2014
Q1 | $64K | Hold |
2
| – | – | ﹤0.01% | 3033 |
|
|
2013
Q4 | $63K | Buy |
2
+1
| +100% | +$31.5K | ﹤0.01% | 2969 |
|
|
2013
Q3 | $33K | Hold |
1
| – | – | ﹤0.01% | 2919 |
|
|
2013
Q2 | $54K | Buy |
+1
| New | +$54K | ﹤0.01% | 2818 |
|